share_log

Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To Competitors

DowjonesNews MarketWatch ·  Nov 2, 2021 16:48

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. (DGX) shed 2.09% to $144.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.37% to 4,630.65 and the Dow Jones Industrial Average rising 0.39% to 36,052.63. The stock's fall snapped a three-day winning streak. Quest Diagnostics Inc. closed $16.33 short of its 52-week high ($160.56), which the company achieved on September 9th.

The stock underperformed when compared to some of its competitors Tuesday, as Laboratory Corp. of America Holdings (LH) fell 0.88% to $286.24, Qiagen N.V. (QGEN) fell 0.92% to $55.15, and Sonic Healthcare Ltd. ADR fell 1.66% to $30.18. Trading volume (1.3 M) eclipsed its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 2, 2021.

-MarketWatch Automation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment